All Things Mobile Analytic Inc (ATMH)

[DJPele]

INVESTOR'S: SUPPLEMENTAL DD ON TRON MERGER & APO

*REPOSTED FOR NEW, POTENTIAL AND CURRENT INVESTOR AWARENESS*

The purpose of this is to combine post's #9982 and #9886. This post is intended to help provide additional supplemental DD to TRON's main Due Diligence MERGER/APO post sticky #9538.



Supplemental DD #1

Please review sticky post #9538. With the help of everyone on this board, it contains a consolidated review, supplemental information and DD on TRON's recent MERGER Press Release and APO with iMed.

TRON is in the process of completing an APO (Alternate Public Offer) which is similar to an IPO, except faster, easier and with private backing.

Links to what an APO is along with examples are contained within sticky post #9538. Other members have also provided details, examples and explanations with their individual post's.

I Highly encourage any new investor's that are interested in TRON to take a look. Also, please review TRON's latest DISCLOSURE, 15c2-11 as well.

http://www.otcmarkets.com/financialReportViewer?symbol=TRON&id=158205

THERE IS a reverse split announced within the 15c2-11 disclosure. As investor's on this board explained, IT'S A RECAPITALIZATION OF THE COMPANY'S STOCK FOR THE COMPLETION OF THE APO and MERGER. I do not recommend reviewing the term "REVERSE SPLIT" as an actual R/S or as a negative. TRON has announced ample information regarding it's merger and the road-map of TRON's future. HOKIEHEAD has made numerous post's explaining how the R/S is in fact a RECAPITALIZATION.

Again, sticky #9538 provides the Press Release and ample supplemental information regarding TRON's merger and APO.



Supplemental DD #2

This takes a closer look into TRON's latest Press Release. Please keep in mind that this is how I interpreted it.

"iMedican is a healthcare project development and management company holding a proprietary technology that provides for the instant verification of a patient’s medical insurance. “iMedcan’s proprietary technology will generate a twenty-five (25%) reduction in patient insurance rejections or denials from insurance payors,” Bostico said."

iMed holds some type of proprietary technology. Information from iMedscan's website (https://imedscan.com) and the PR shows that it's potentially a device that provides instant verification of patient's medical insurance. Here's more:

"In March, 2016, iMedScan entered into an agreement with Acuant Corporation of Los Angeles, California to employ its proprietary, hosted scanning solution on patient’s driver’s licenses and insurance cards."

I am assuming the agreement between Acuant and iMedscan is iMedscan allowing Acuant to utilize iMedscan's proprietary technology, scanning licenses and ID cards for the instant verification of patient's medical insurances.

"Most recently, in June, 2016, iMedScan finalized a test program with Change Healthcare, formerly Emdeon Corpoation, utilizing an electronic data interchange for verifying and validating patients’ health insurance. “We estimate a fifty (50%) percent net profit recapture from each medical office that adopts our technology,” Bostico noted. Currently, in addition to traditional medical offices, iMedScan is focusing on the further development and commercialization of kiosk devices hosting the company’s scanning solution."

"Kiosk devices hosting the company’s scanning solution." There it is again. iMedscan and Change Healthcare (formerly Emdeon, who was bought by Black Stone) finalized a test program, estimating a 50% net profit recapture from each medical office that adopts our (iMedscan's) technology. Change Healthcare will use iMedscan's proprietary technology to verify and validate patients health insurance.

Just an FYI, Change Healthcare is a HUGE corporation.

iMedscan's reason to create this technology is to eliminate healthcare claim rejections across the United States. Reducing claim rejections decreases company costs.

From conducting some Due Diligence on TRON, it looks as if ACUANT and Change Healthcare will be using iMedscan's proprietary technology with regards to healthcare.

Fabrizio Bosticco is the CEO of both iMedscan and TRON.



Supplemental DD #3

Here are links SMITTER found regarding Black Stone and Change Healthcare's history.

Black Stone Bought Emdeon for 3 Billion.

http://dealbook.nytimes.com/2011/08/04/blackstone-to-buy-emdeon-for-3-billion/?_r=0

Emedon bought Change Healthcare for 135 Million.

http://www.tennessean.com/story/money/2014/11/19/emdeon-buys-change-healthcare/19306989/

Emdeon to re-brand as Change Healthcare.

http://www.prnewswire.com/news-releases/emdeon-to-rebrand-as-change-healthcare-300137812.html